Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026)
Charlotte's Web Holdings (CWBHF) reported Cash from Financing Activities of -$41000.0 for Q1 2026, down 156.25% quarter-over-quarter from -$16000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Cash from Financing Activities data on file, last reported at -$41000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$41000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$91000.0 (down 93.62% YoY), and the FY2025 annual result was -$50000.0, up 65.52% from the prior year.
- Cash from Financing Activities slipped to -$41000.0 in Q1 2026 per CWBHF's latest filing, from -$16000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $52.7 million in Q4 2022 and troughed at -$265000.0 in Q3 2022.
- A 5-year average of $3.2 million and a median of -$22500.0 in 2024 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 883.65% in 2022 and fell as far as 393.75% in 2022.
- A 5-year view of Cash from Financing Activities shows it stood at $52.7 million in 2022, then slumped by 100.09% to -$49000.0 in 2023, then soared by 75.51% to -$12000.0 in 2024, then tumbled by 33.33% to -$16000.0 in 2025, then slumped by 156.25% to -$41000.0 in 2026.
- Business Quant data shows CWBHF's Cash from Financing Activities at -$41000.0 in Q1 2026, -$16000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | -41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Dec 31, 2025 | -16,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Jun 30, 2024 | -20,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Mar 31, 2024 | -98,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -127,000.00 |
| Sep 30, 2023 | -127,000.00 |